https://www.selleckchem.com/products/odm-201.html
Overall, the patients who received LMWH had lower mortality (1.4% vs 3.6%, p0.01), DVT (1.7% vs 3.7%, p0.01), and hospital LOS among survivors (7 days vs 9 days, p0.01) compared to those who received UFH. There was no significant difference in the ICU LOS among survivors and the incidence of PE between the two groups. LMWH is associated with increased survival, lower rates of DVT, and decreased hospital LOS compared to UFH among pediatric trauma patients age 10-17 years. Level III Prophylactic. Prophylactic. Prophylactic. Th
Like
Comment
Share
